Diverse ways to control p27Kip1 function -: miRNAs come into play

被引:50
作者
le Sage, Carlos [1 ]
Nagel, Remco [1 ]
Agami, Reuven [1 ]
机构
[1] Netherlands Canc Inst, Div Tumor Biol, Amsterdam, Netherlands
关键词
miRNA; p27; miR-221; cancer; target identification;
D O I
10.4161/cc.6.22.4900
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
microRNAs (miRNAs) are small RNA molecules controlling messenger RNA (mRNA) and protein abundance. Since their discovery, research has been aimed at identifying the functions and target genes of miRNAs. A number of computer algorithms have been developed capable of predicting putative targets for any given miRNA. However, they might predict many false-positive targets and on top of that some true targets could be missed. This reflects the incomplete knowledge we still have concerning the rules governing true and effective miRNA-mRNA interactions. To experimentally identify miRNA-target genes, we have recently developed a genetic approach and employed it on p27(Kip1), a haplo-insufficient tumor suppressor and cell cycle inhibitor. Here we review the difficulties interpreting the data from available computer algorithms, and critically address the pros and cons of our genetic screening method. Additionally, we focus on the different ways in which p27 is managed, argue how miRNAs could be involved in the regulation of p27 in both normal and malignant conditions, and discuss possible use of this knowledge for cancer therapy.
引用
收藏
页码:2742 / 2749
页数:8
相关论文
共 108 条
[91]   G1 PHASE PROGRESSION - CYCLING ON CUE [J].
SHERR, CJ .
CELL, 1994, 79 (04) :551-555
[92]   PKB/Akt mediates cell-cycle progression by phosphorylation of p27Kip1 at threonine 157 and modulation of its cellular localization [J].
Shin, I ;
Yakes, FM ;
Rojo, F ;
Shin, NY ;
Bakin, AV ;
Baselga, J ;
Arteaga, CL .
NATURE MEDICINE, 2002, 8 (10) :1145-1152
[93]  
Slingerland J, 2000, J CELL PHYSIOL, V183, P10, DOI 10.1002/(SICI)1097-4652(200004)183:1<10::AID-JCP2>3.3.CO
[94]  
2-9
[95]   A CDK-independent function of mammalian Cks1:: Targeting of SCFSkp2 to the CDK inhibitor p27Kip1 [J].
Spruck, C ;
Strohmaier, H ;
Watson, M ;
Smith, APL ;
Ryan, A ;
Krek, W ;
Reed, SI .
MOLECULAR CELL, 2001, 7 (03) :639-650
[96]   p45SKP2 promotes p27Kip1 degradation and induces S phase in quiescent cells [J].
Sutterlüty, H ;
Chatelain, E ;
Marti, A ;
Wirbelauer, C ;
Senften, M ;
Müller, U ;
Krek, W .
NATURE CELL BIOLOGY, 1999, 1 (04) :207-214
[97]   Differential regulation of microRNAs by p53 revealed by massively parallel Sequencing -: miR-34a is a p53 target that induces apoptosis and G1-arrest [J].
Tarasov, Valery ;
Jung, Peter ;
Verdoodt, Berlinda ;
Lodygin, Dmitri ;
Epanchintsev, Alexey ;
Menssen, Antje ;
Meister, Gunter ;
Hermeking, Heiko .
CELL CYCLE, 2007, 6 (13) :1586-1593
[98]   P27Kip1 ubiquitination and degradation is regulated by the SCFSkp2 complex through phosphorylated Thr187 in p27 [J].
Tsvetkov, LM ;
Yeh, KH ;
Lee, SJ ;
Sun, H ;
Zhang, H .
CURRENT BIOLOGY, 1999, 9 (12) :661-664
[99]   Cytoplasmic relocalization and inhibition of the cyclin-dependent kinase inhibitor p27Kip1 by PKB/Akt-mediated phosphorylation in breast cancer [J].
Viglietto, G ;
Motti, ML ;
Bruni, P ;
Melillo, RM ;
D'Alessio, A ;
Califano, D ;
Vinci, F ;
Chiappetta, G ;
Tsichlis, P ;
Bellacosa, A ;
Fusco, A ;
Santoro, M .
NATURE MEDICINE, 2002, 8 (10) :1136-1144
[100]   Phosphorylation-dependent degradation of the cyclin-dependent kinase inhibitor p27(Kip1) [J].
Vlach, J ;
Hennecke, S ;
Amati, B .
EMBO JOURNAL, 1997, 16 (17) :5334-5344